Mihir Desai
Papers
2
Total Citations
52
H-Index
2
About
Mihir Desai is a prominent urological surgeon and clinical researcher whose work spans minimally invasive surgical technologies, benign prostatic hyperplasia (BPH) management, and advanced stone disease treatment. He has made significant contributions to the development and clinical validation of innovative surgical platforms that aim to improve patient outcomes while reducing procedural morbidity. Among his most recognized contributions is his involvement in the WATER II clinical trial, which evaluated Aquablation therapy — a robotic, image-guided waterjet ablation technique — for men with large-volume prostates (80–150 mL). The 5-year results, published in 2023 and already accumulating 49 citations, demonstrated durable safety and efficacy in a historically challenging patient population, helping establish Aquablation as a meaningful alternative to traditional surgical interventions for BPH. His more recent work explores robotic-assisted kidney stone management, including a detailed technical guide for the novel MONARCH™ platform, combining mini-percutaneous nephrolithotomy with flexible ureteroscopic lithotripsy — reflecting his commitment to advancing robotic integration in endourology. Desai's research consistently bridges rigorous clinical trial methodology with cutting-edge surgical innovation, making his work highly relevant for urologists, trainees, and researchers seeking evidence-based guidance on emerging therapeutic technologies.
Research Focus
Key Achievements
Top Papers
- 1
- 2